Concepedia
Statistics
Publications
5
Citations
237
H-Index
Active since
2017
Affiliations
Amgen (Germany)(Current)
Amgen (United States)
Bioanalytica (Switzerland)
Markus Muenz is an author at Amgen (Germany) specializing in immunology, immunotherapy, and antibody engineering.
Publications per year
2017–2021
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors
Brian Belmontes, Deepali V. Sawant, Wendy Zhong et al. · Science Translational Medicine · 2021 · 116 citations
Life Sciences, Immunology, Oncology +17
Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs
Johannes Brozy, Erika Schlaepfer, Christina K. S. Mueller et al. · Journal of Virology · 2018 · 47 citations · Full text
Life Sciences, Biomolecular Engineering, Immunology +17
Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII
Alexander Sternjak, Fei Lee, Oliver S. Thomas et al. · Molecular Cancer Therapeutics · 2021 · 30 citations · Full text
Medicine, Immunology, Oncology +17
Abstract 55: Generation of half-life extended anti-CD33 BiTE® antibody constructs compatible with once-weekly dosing
Tara Arvedson, Mercedesz Balázs, Pamela Bogner et al. · Cancer Research · 2017 · 29 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection
Jochen Pendzialek, Kenny Roose, Anouk Smet et al. · Antiviral Research · 2017 · 15 citations
Life Sciences, Immunology, Infectious Diseases +17
1–5 of 5